NextCure Inc (FRA:2US)
€ 0.783 -0.138 (-14.98%) Market Cap: 22.04 Mil Enterprise Value: -45.05 Mil PE Ratio: 0 PB Ratio: 0.30 GF Score: 28/100

NextCure Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 06:00PM GMT
Release Date Price: €6.57 (+5.29%)
Alec Warren Stranahan
BofA Securities, Research Division - Associate

Okay. Hello, everyone, and welcome to Day 3 of the 2021 Bank of America Healthcare Conference. Thank you for joining this session with NextCure. My name is Alec Stranahan, and I'm the analyst covering NextCure here at BofA. I'm pleased to be joined with -- today, I'm joined by Michael Richman, President and CEO of NextCure. And I believe Michael has some few slides to start, and then we can jump into Q&A at this time. So with that, Michael, over to you.

Michael S. Richman
NextCure, Inc. - Co-Founder, CEO, President & Director

Great. Well, thank you very much, Alec, and thank you very much for the opportunity to speak at the BofA Securities Conference. It's a pleasure to give you a quick update on NextCure. So hopefully, everyone has the slides in front of them.

The first slide really addresses the key vision for the organization, and this involves developing next-generation immuno medicines. On Slide 2 is our forward-looking statements.

On Slide 3, these are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot